April 28, 2022

4 Success Strategies for Biomarker-Driven Clinical Trials

Biomarker-driven strategies are known to increase the likelihood of drug approvals but optimizing their integration into clinical research poses several challenges.
April 4, 2022

IVD Manufacturers & EU IVD Regulation Changes (May 2022)

New EU Regulations will impact in vitro diagnostic manufacturers in a number of ways. See a breakdown of the impact of these changes.
March 16, 2022

Technologies that Make Decentralized Clinical Trials Tick

Technological advances are lowering the barrier to clinical trial entry, allowing more people in more locations to enroll.
March 14, 2022

Decentralized trial strategies and their impact in rare disease studies

Decentralized clinical trial strategies lower the barrier to study enrollment for people with rare diseases, increasing patient choice and reducing the burden of participation.
February 16, 2022

The 10 Proposed Revisions to UK Clinical Trial Regulations

Read the 10 legislative proposals submitted to help transform the regulation of clinical trials in the UK.
February 9, 2022

Proposed Legislative Changes for UK Clinical Trials

Proposed changes could disrupt the way sponsors approach clinical trials in the UK. Read more about the strategy inspiring the change.
February 1, 2022

Clinical Study Reports (CSR): Types and Use Cases

The Clinical Study Report is arguably the most important document emerging from a clinical trial. Learn the four types and when to use them.
January 25, 2022

The Growing Role of Medical Writers for an Effective CSR

Learn why a well-written clinical study report (CSR), prepared by a seasoned medical writer, is essential to timely regulatory approval.
January 19, 2022

Phase I Clinical Trial Designs: Bayesian Optimal Interval Design (BOIN)

Bayesian Optimal Interval Design (BOIN) is an agile, effective and reliable phase I clinical trial approach increasing in popularity. What makes BOIN an appropriate approach for trials?